James officially joined the University of Wolverhampton in September 2008 from Keele University, where he held the position of Senior Ranking Research Fellow in a multi-million Euros adventure consortium with German, Dutch, and UK partners under the support of SIXTH FRAMWORK PROGRAMME: New and emerging science and technologies (NEST)- FP6-NEST-2006-INTEFRATING Grant agreement number: 28861.
James has over 25 years experience in higher education and 4 years in a R&D institution. James has established excellent connections and a rich history of successful activities involving external academic institutions, healthcare service, and industrial/commercial organisations. In 1998, James became Project Manager in Polymer Processing Group at Singapore Institute of Manufacturing Technology, dealing with surface adhesion related industrial projects resulting one patent. James received annual achievement award in 2000 and initiated a pioneer program of 3D printing with Singapore University Hospital and Private Company in 2001. When James was at UK Centre for Tissue Engineering, a 10 million Interdisciplinary Research Collaboration (IRcol) between University of Liverpool and University of Manchester under the support of the Research Councils (BBSRC, MRC, EPSRC), James was invited on behalf of UK Centre for Tissue Engineering giving a short course on Nanoscience and Tissue Engineering, in iNanoSchool, Autumn School 2005, at Fuglsøcentret, University of Aarhus, Denmark, in 2005. Being a specialist in biomaterials, James initiated a FP7 Marie Curie IRSES exchange programme of Hyanji Scaffold at Keele University in 2008, participating in the programme as an honorary senior lecturer since 2009. In 2011, James initiated another Marie Curie FP7 IRSES exchange programme of Heptag Exchange at the University of Wolverhampton and then first FP7 Marie Curie Incoming Fellowship with colleague in 2013. James was appointed Professor in Pharmaceutics in 2014. Under James’ directorship, Cancer Targeted Delivery Initiative was formed in 2012, joint Nanomedicine program with Keele University was activated in 2016, and global 3D Printing and its formulation network was set in 2018.
James was board director of Academy of Pharmaceutical Sciences of Great Britain from 2010 to 2014. James is also a Guest Professor at Sichuan University, China Since 2008; Editorial Board for Nanoscience and Nanotechnology Letter, USA from 2008 to 2012; an honorary senior lecturer at Keele University, UK since 2009; Expert Evaluator for Horizon 2020 Marie Sklodowska-Curie Action-RISE since 2014; and Guest Editor for Materials Special Issue: Materials for Drug Delivery and Pharmaceutical Considerations in 2016~17.
James is author and co-author of over 80 publications and 3 book chapters, filed 6 patents, and delivered over 13 presentations nationally and internationally.